Details for New Drug Application (NDA): 216604
✉ Email this page to a colleague
The generic ingredient in DEXMEDETOMIDINE HYDROCHLORIDE is dexmedetomidine hydrochloride. There are fourteen drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the dexmedetomidine hydrochloride profile page.
Summary for 216604
| Tradename: | DEXMEDETOMIDINE HYDROCHLORIDE |
| Applicant: | Amneal |
| Ingredient: | dexmedetomidine hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 216604
| Mechanism of Action | Adrenergic alpha2-Agonists |
| Physiological Effect | General Anesthesia |
Medical Subject Heading (MeSH) Categories for 216604
Suppliers and Packaging for NDA: 216604
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DEXMEDETOMIDINE HYDROCHLORIDE | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 216604 | ANDA | Amneal Pharmaceuticals LLC | 70121-1711 | 70121-1711-2 | 15 POUCH in 1 CARTON (70121-1711-2) / 1 BAG in 1 POUCH / 50 mL in 1 BAG |
| DEXMEDETOMIDINE HYDROCHLORIDE | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 216604 | ANDA | Amneal Pharmaceuticals LLC | 70121-1711 | 70121-1711-9 | 24 POUCH in 1 CARTON (70121-1711-9) / 1 BAG in 1 POUCH / 50 mL in 1 BAG |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML) | ||||
| Approval Date: | May 15, 2023 | TE: | AP | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML) | ||||
| Approval Date: | May 15, 2023 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
